Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Ciprofloxacin at low levels disrupts colonization resistance of human fecal microflora growing in chemostats.

Carman RJ, Simon MA, Fernández H, Miller MA, Bartholomew MJ.

Regul Toxicol Pharmacol. 2004 Dec;40(3):319-26.

PMID:
15546686
2.

Effects of low levels of ciprofloxacin on a chemostat model of the human colonic microflora.

Carman RJ, Woodburn MA.

Regul Toxicol Pharmacol. 2001 Jun;33(3):276-84.

PMID:
11407931
3.

Impact of rufloxacin and ciprofloxacin on the intestinal microflora in a germ-free mice model.

Gismondo MR, Drago L, Lombardi A, Fassina C, Cesana M.

Chemotherapy. 1995 Jul-Aug;41(4):281-8.

PMID:
7555209
4.

Impact of residual and therapeutic doses of ciprofloxacin in the human-flora-associated mice model.

Perrin-Guyomard A, Poul JM, Corpet DE, Sanders P, Fernández AH, Bartholomew M.

Regul Toxicol Pharmacol. 2005 Jul;42(2):151-60.

PMID:
15963836
5.

Antimicrobial activity of intravenous quinolones on the intestinal microflora in dogs.

Thadepalli H, Chuah SK, Thadepalli CD, Mandal AK.

Chemotherapy. 1991;37(1):6-14.

PMID:
2013243
6.

Impact of ciprofloxacin in the human-flora-associated (HFA) rat model: comparison with the HFA mouse model.

Perrin-Guyomard A, Poul JM, Laurentie M, Sanders P, Fernández AH, Bartholomew M.

Regul Toxicol Pharmacol. 2006 Jun;45(1):66-78. Epub 2006 Mar 24.

PMID:
16563587
8.

Impact of cyadox on human colonic microflora in chemostat models.

Hao H, Guo W, Iqbal Z, Cheng G, Wang X, Dai M, Huang L, Wang Y, Peng D, Liu Z, Yuan Z.

Regul Toxicol Pharmacol. 2013 Dec;67(3):335-43. doi: 10.1016/j.yrtph.2013.08.011. Epub 2013 Aug 22.

PMID:
23973379
9.
10.
11.

Effects of microcin 24-producing Escherichia coli on shedding and multiple-antimicrobial resistance of Salmonella enterica serotype typhimurium in pigs.

Frana TS, Carlson SA, Rauser DC, Jones BD, Fergen BJ, Griffith RW.

Am J Vet Res. 2004 Dec;65(12):1616-20.

PMID:
15631023
12.

Effect of antimicrobial dosage regimen on Salmonella and Escherichia coli isolates from feeder swine.

Wagner BA, Straw BE, Fedorka-Cray PJ, Dargatz DA.

Appl Environ Microbiol. 2008 Mar;74(6):1731-9. doi: 10.1128/AEM.01132-07. Epub 2008 Jan 25.

13.
14.

Effects of roxithromycin on fecal bacteria in human volunteers and resistance to colonization in gnotobiotic mice.

Pecquet S, Chachaty E, Tancrède C, Andremont A.

Antimicrob Agents Chemother. 1991 Mar;35(3):548-52.

15.

The contribution of Escherichia coli to microbial colonization resistance.

Vollaard EJ, Clasener HA, Janssen AJ.

J Antimicrob Chemother. 1990 Sep;26(3):411-8.

PMID:
2228829
16.

Antimicrobial drug resistance of fecal Escherichia coli and Salmonella spp. isolates from United States dairy cows.

Lundin JI, Dargatz DA, Wagner BA, Lombard JE, Hill AE, Ladely SR, Fedorka-Cray PJ.

Foodborne Pathog Dis. 2008 Feb;5(1):7-19. doi: 10.1089/fpd.2007.0018.

PMID:
18260811
17.

Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary and fecal microflora.

Bergan T, Delin C, Johansen S, Kolstad IM, Nord CE, Thorsteinsson SB.

Antimicrob Agents Chemother. 1986 Feb;29(2):298-302.

19.

Effects of sarafloxacin hydrochloride on human enteric bacteria under simulated human gut conditions.

McConville ML, Dijkstra JW, Stamm JM, van Saene JJ, Nouws JF.

Vet Q. 1995 Mar;17(1):1-5.

PMID:
7610549
20.

Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken.

Lee YJ, Cho JK, Kim KS, Tak RB, Kim AR, Kim JW, Im SK, Kim BH.

J Microbiol. 2005 Oct;43(5):391-7.

PMID:
16273029

Supplemental Content

Support Center